المؤلفون: Sommer C; Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Member of the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Hannover, Germany., Jacob S; Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Member of the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Hannover, Germany., Bargmann T; Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Member of the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Hannover, Germany., Shoaib M; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Luxembourg., Alshaikhdeeb B; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Luxembourg., Satagopam VP; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Luxembourg., Dehmel S; Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Member of the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Hannover, Germany., Neuhaus V; Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Member of the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Hannover, Germany., Braun A; Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Member of the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Hannover, Germany; Institute of Immunology, Hannover Medical School, Hannover, Germany., Sewald K; Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Member of the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Hannover, Germany. Electronic address: katherina.sewald@item.fraunhofer.de.

المصدر: Clinical immunology (Orlando, Fla.) [Clin Immunol] 2024 Sep; Vol. 266, pp. 110288. Date of Electronic Publication: 2024 Jun 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 100883537 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-7035 (Electronic) Linking ISSN: 15216616 NLM ISO Abbreviation: Clin Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Interleukin-2*/immunology , Interleukin-2*/genetics , Killer Cells, Natural*/immunology , Killer Cells, Natural*/drug effects, Humans ; Signal Transduction ; Phenotype ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/drug effects ; Interleukin-2 Receptor beta Subunit/genetics ; Interleukin-2 Receptor beta Subunit/immunology ; CD4-Positive T-Lymphocytes/immunology ; T-Lymphocytes, Regulatory/immunology

المؤلفون: Hayashi H; Medical University Research Administrator, Nagasaki University School of Medicine, Nagasaki 852-8523, Japan.; Centre for Oncology and Immunology, Hong Kong Science Park, Hong Kong Special Administrative Region 999077, China., Mak TW; Center for Medical Innovation, Nagasaki University, Nagasaki 852-8588, Japan.; Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G 2M9, Canada.; Department of Pathology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region 999077, China., Tanaka Y; Centre for Oncology and Immunology, Hong Kong Science Park, Hong Kong Special Administrative Region 999077, China., Kubo Y; Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan., Izumida M; Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan., Urae R; Souseikai Clinical Research Center, Fukuoka 812-0025, Japan., Matsuyama T; Department of Forensic Pathology and Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8523, Japan.

المصدر: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Aug 13; Vol. 121 (33), pp. e2318190121. Date of Electronic Publication: 2024 Aug 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE

مواضيع طبية MeSH: Receptor, Interferon alpha-beta*/metabolism , Receptor, Interferon alpha-beta*/genetics , T-Lymphocytes*/metabolism , T-Lymphocytes*/immunology , Interleukin-2*/metabolism , Interferon-gamma*/metabolism, Humans ; Receptors, Interleukin-2/metabolism ; Receptors, Interleukin-2/genetics ; Protein Binding ; Lymphocyte Activation ; HEK293 Cells

المؤلفون: Zhang R; Sino-French Hoffmann Institute, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.; Department of Clinical Medicine, The Third Clinical School of Guangzhou Medical University, Guangzhou, China., Zhao Y; Sino-French Hoffmann Institute, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.; The Second Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, Guangdong Provincial Key Laboratory of Allergy & Clinical Immunology, Guangzhou Medical University, Guangzhou, China., Chen X; Sino-French Hoffmann Institute, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.; The Second Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, Guangdong Provincial Key Laboratory of Allergy & Clinical Immunology, Guangzhou Medical University, Guangzhou, China., Zhuang Z; Department of Clinical Medicine, The Third Clinical School of Guangzhou Medical University, Guangzhou, China., Li X; Sino-French Hoffmann Institute, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China., Shen E; Sino-French Hoffmann Institute, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.; The Second Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, Guangdong Provincial Key Laboratory of Allergy & Clinical Immunology, Guangzhou Medical University, Guangzhou, China.; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.

المصدر: International reviews of immunology [Int Rev Immunol] 2024 May; Vol. 43 (3), pp. 113-137. Date of Electronic Publication: 2023 Oct 26.

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8712260 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1563-5244 (Electronic) Linking ISSN: 08830185 NLM ISO Abbreviation: Int Rev Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Autoimmune Diseases*/therapy , Autoimmune Diseases*/immunology , Interleukin-2*/therapeutic use , T-Lymphocytes, Regulatory*/immunology, Animals ; Humans ; Receptors, Interleukin-2/metabolism ; Receptors, Interleukin-2/immunology

المؤلفون: Morotti M; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Grimm AJ; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Hope HC; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Arnaud M; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Desbuisson M; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Rayroux N; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Barras D; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Masid M; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Murgues B; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Chap BS; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Ongaro M; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Rota IA; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Ronet C; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Minasyan A; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Chiffelle J; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Lacher SB; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Bobisse S; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Murgues C; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Ghisoni E; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Ouchen K; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Bou Mjahed R; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Benedetti F; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Abdellaoui N; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Turrini R; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland., Gannon PO; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Zaman K; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Mathevet P; Department of Gynaecology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Lelievre L; Department of Gynaecology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Crespo I; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Conrad M; Institute of Metabolism and Cell Death, Molecular Target and Therapeutics Centre, Helmholtz Munich, Neuherberg, Germany., Verdeil G; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Kandalaft LE; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Dagher J; Unit of Translational Oncopathology, Institute of Pathology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Corria-Osorio J; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Doucey MA; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland., Ho PC; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Harari A; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Vannini N; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland., Böttcher JP; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Dangaj Laniti D; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland. denarda.dangaj@chuv.ch.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland. denarda.dangaj@chuv.ch.; Agora Cancer Research Center, Lausanne, Switzerland. denarda.dangaj@chuv.ch., Coukos G; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland. george.coukos@chuv.ch.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland. george.coukos@chuv.ch.; Agora Cancer Research Center, Lausanne, Switzerland. george.coukos@chuv.ch.

المصدر: Nature [Nature] 2024 May; Vol. 629 (8011), pp. 426-434. Date of Electronic Publication: 2024 Apr 24.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

مواضيع طبية MeSH: CD8-Positive T-Lymphocytes*/cytology , CD8-Positive T-Lymphocytes*/immunology , CD8-Positive T-Lymphocytes*/metabolism , Cell Proliferation* , Dinoprostone*/metabolism , Interleukin-2*/antagonists & inhibitors , Interleukin-2*/immunology , Interleukin-2*/metabolism , Lymphocytes, Tumor-Infiltrating*/cytology , Lymphocytes, Tumor-Infiltrating*/immunology , Lymphocytes, Tumor-Infiltrating*/metabolism , Mitochondria*/metabolism , Signal Transduction*, Animals ; Humans ; Mice ; Down-Regulation ; Ferroptosis ; Interleukin Receptor Common gamma Subunit/biosynthesis ; Interleukin Receptor Common gamma Subunit/deficiency ; Interleukin Receptor Common gamma Subunit/metabolism ; Interleukin-2 Receptor beta Subunit/metabolism ; Oxidative Stress ; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha/metabolism ; Receptors, Prostaglandin E, EP2 Subtype/metabolism ; Receptors, Prostaglandin E, EP2 Subtype/antagonists & inhibitors ; Receptors, Prostaglandin E, EP4 Subtype/metabolism ; Receptors, Prostaglandin E, EP4 Subtype/antagonists & inhibitors ; TOR Serine-Threonine Kinases/metabolism ; Tumor Microenvironment/immunology

المؤلفون: Sommer C; Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Member of the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Hannover, Germany., Cohen JN; Department of Dermatology, University of California, San Francisco, California, USA.; Department of Pathology, University of California, San Francisco, California, USA., Dehmel S; Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Member of the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Hannover, Germany., Neuhaus V; Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Member of the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Hannover, Germany., Schaudien D; Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Member of the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Hannover, Germany., Braun A; Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Member of the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Hannover, Germany.; Institute of Immunology, Hannover Medical School, Hannover, Germany., Sewald K; Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Member of the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Hannover, Germany., Rosenblum MD; Department of Dermatology, University of California, San Francisco, California, USA.

المصدر: European journal of immunology [Eur J Immunol] 2024 Apr; Vol. 54 (4), pp. e2350580. Date of Electronic Publication: 2024 Mar 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 1273201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-4141 (Electronic) Linking ISSN: 00142980 NLM ISO Abbreviation: Eur J Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Interleukin-2*/adverse effects , Interleukin-2*/metabolism , Immunity, Innate*, Mice ; Humans ; Animals ; Lymphocytes ; Inflammation ; T-Lymphocytes, Regulatory ; Interleukin-2 Receptor alpha Subunit/metabolism ; Skin

المؤلفون: Lokau J; Institute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.; Department of Pathology, Medical Faculty, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany., Petasch LM; Department of Pathology, Medical Faculty, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany., Garbers C; Institute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.

المصدر: Immunology [Immunology] 2024 Mar; Vol. 171 (3), pp. 377-387. Date of Electronic Publication: 2023 Nov 30.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 0374672 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2567 (Electronic) Linking ISSN: 00192805 NLM ISO Abbreviation: Immunology Subsets: MEDLINE

مواضيع طبية MeSH: Interleukin Receptor Common gamma Subunit* , Interleukin-2*, Humans ; Interleukin-2 Receptor alpha Subunit ; Receptors, Interleukin-2

المؤلفون: Shouse AN; Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA., LaPorte KM; Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA., Malek TR; Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA. Electronic address: tmalek@med.miami.edu.

المصدر: Immunity [Immunity] 2024 Mar 12; Vol. 57 (3), pp. 414-428.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 9432918 Publication Model: Print Cited Medium: Internet ISSN: 1097-4180 (Electronic) Linking ISSN: 10747613 NLM ISO Abbreviation: Immunity Subsets: MEDLINE

مواضيع طبية MeSH: Interleukin-2*/metabolism , Neoplasms*, Humans ; Autoimmunity ; Receptors, Interleukin-2 ; T-Lymphocyte Subsets

المؤلفون: Huang H; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China., Zhang S; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China., Zhao Y; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China., Xu R; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China., Tan WS; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China., Cai H; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China.

المصدر: Biotechnology journal [Biotechnol J] 2024 Mar; Vol. 19 (3), pp. e2300654.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-VCH Verlag Country of Publication: Germany NLM ID: 101265833 Publication Model: Print Cited Medium: Internet ISSN: 1860-7314 (Electronic) Linking ISSN: 18606768 NLM ISO Abbreviation: Biotechnol J Subsets: MEDLINE

مواضيع طبية MeSH: Interleukin-2*/metabolism , Killer Cells, Natural*/metabolism, Receptors, Interleukin-2/metabolism ; Cytokines/metabolism ; Cell Membrane

المؤلفون: Charley KR; Division of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112.; Huntsman Cancer Institute, University of Utah Health, Salt Lake City, UT 84112., Ramstead AG; Division of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112.; Huntsman Cancer Institute, University of Utah Health, Salt Lake City, UT 84112., Matous JG; Division of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112.; Huntsman Cancer Institute, University of Utah Health, Salt Lake City, UT 84112., Kumaki Y; Division of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112.; Huntsman Cancer Institute, University of Utah Health, Salt Lake City, UT 84112., Sircy LM; Division of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112., Hale JS; Division of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112., Williams MA; Division of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112.; Huntsman Cancer Institute, University of Utah Health, Salt Lake City, UT 84112.

المصدر: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2024 Feb 15; Vol. 212 (4), pp. 586-595.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association of Immunologists Country of Publication: United States NLM ID: 2985117R Publication Model: Print Cited Medium: Internet ISSN: 1550-6606 (Electronic) Linking ISSN: 00221767 NLM ISO Abbreviation: J Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Interleukin-2* , Th1 Cells*, Animals ; Mice ; CD4-Positive T-Lymphocytes ; Cell Differentiation ; Immunologic Memory ; Interleukin-2 Receptor alpha Subunit ; Mice, Inbred C57BL ; Receptors, Antigen, T-Cell

المؤلفون: Ozdilli K; From the Department of Medical Biology (Ozdilli), Faculty of Medicine, Medipol University, from the Department of Psychiatry (Aytac), Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Institute of Graduate Studies in Health Sciences (Aytac, Tuncel, Oyaci, Pehlivan), Department of Medical Biology (Tuncel, Oyaci, Pehlivan), Istanbul Faculty of Medicine, Istanbul University, and from Department of Hematology (Pehlivan M), Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey., Mervan Aytac H; From the Department of Medical Biology (Ozdilli), Faculty of Medicine, Medipol University, from the Department of Psychiatry (Aytac), Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Institute of Graduate Studies in Health Sciences (Aytac, Tuncel, Oyaci, Pehlivan), Department of Medical Biology (Tuncel, Oyaci, Pehlivan), Istanbul Faculty of Medicine, Istanbul University, and from Department of Hematology (Pehlivan M), Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey., Ceren Tuncel F; From the Department of Medical Biology (Ozdilli), Faculty of Medicine, Medipol University, from the Department of Psychiatry (Aytac), Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Institute of Graduate Studies in Health Sciences (Aytac, Tuncel, Oyaci, Pehlivan), Department of Medical Biology (Tuncel, Oyaci, Pehlivan), Istanbul Faculty of Medicine, Istanbul University, and from Department of Hematology (Pehlivan M), Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey., Oyaci Y; From the Department of Medical Biology (Ozdilli), Faculty of Medicine, Medipol University, from the Department of Psychiatry (Aytac), Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Institute of Graduate Studies in Health Sciences (Aytac, Tuncel, Oyaci, Pehlivan), Department of Medical Biology (Tuncel, Oyaci, Pehlivan), Istanbul Faculty of Medicine, Istanbul University, and from Department of Hematology (Pehlivan M), Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey., Pehlivan M; From the Department of Medical Biology (Ozdilli), Faculty of Medicine, Medipol University, from the Department of Psychiatry (Aytac), Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Institute of Graduate Studies in Health Sciences (Aytac, Tuncel, Oyaci, Pehlivan), Department of Medical Biology (Tuncel, Oyaci, Pehlivan), Istanbul Faculty of Medicine, Istanbul University, and from Department of Hematology (Pehlivan M), Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey., Pehlivan S; From the Department of Medical Biology (Ozdilli), Faculty of Medicine, Medipol University, from the Department of Psychiatry (Aytac), Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Institute of Graduate Studies in Health Sciences (Aytac, Tuncel, Oyaci, Pehlivan), Department of Medical Biology (Tuncel, Oyaci, Pehlivan), Istanbul Faculty of Medicine, Istanbul University, and from Department of Hematology (Pehlivan M), Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.

المصدر: Neurosciences (Riyadh, Saudi Arabia) [Neurosciences (Riyadh)] 2024 Jan; Vol. 29 (1), pp. 51-56.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Armed Forces Hospital Country of Publication: Saudi Arabia NLM ID: 101252453 Publication Model: Print Cited Medium: Internet ISSN: 1319-6138 (Print) Linking ISSN: 13196138 NLM ISO Abbreviation: Neurosciences (Riyadh) Subsets: MEDLINE

مواضيع طبية MeSH: Interleukin-2*/genetics , Schizophrenia*/genetics, Animals ; Humans ; Mice ; Case-Control Studies ; Epistasis, Genetic ; Polymorphism, Genetic ; Turkey ; Receptors, Interleukin-2/metabolism